The Board of Directors of Korea Arlico Pharm Co.,Ltd. has authorized a buyback plan on October 6, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,800 KRW | -0.10% |
|
-1.84% | -15.79% |
2023 | Korea Arlico Pharm Co.,Ltd. announced that it has received KRW 10 billion in funding | CI |
2023 | Korea Arlico Pharm Co.,Ltd. announced that it expects to receive KRW 10 billion in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-15.79% | 53.39M | |
+20.76% | 43.77B | |
+28.00% | 22.83B | |
+20.25% | 15.56B | |
+18.82% | 14.34B | |
+55.83% | 12.96B | |
-0.05% | 6.79B | |
-12.70% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |
- Stock Market
- Equities
- A260660 Stock
- News Korea Arlico Pharm Co.,Ltd.
- Korea Arlico Pharm Co.,Ltd. authorizes a Buyback Plan.